Rhythm Pharmaceuticals, Inc. (RYTM) NASDAQ
86.29
-1.83(-2.08%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
86.29
-1.83(-2.08%)
Currency In USD
| Market Cap | 6.96B |
| Enterprise Value | 7.15B |
| P/E Ratio | -29.36 |
| PEG Ratio | 91.02 |
| Price/Sales Ratio | 31.05 |
| Price/Book Ratio | 41.5 |
| Enterprise/Revenue | 32.06 |
| Enterprise/EBITDA | -34.94 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.04 |
| Operating Margin | -1.01 |
| Return On Assets | -0.41 |
| Return On Equity | -1.79 |
| Revenue | 189.76M |
| Revenue/Share | 2.84 |
| Gross Profit | 170.27M |
| EBITDA | -174.12M |
| Net Income | -196.54M |
| Diluted EPS | -3.11 |
| Total Cash | 388.95M |
| Total Cash/Share | 5.82 |
| Total Debt | 246.47M |
| Total Debt/Equity | 1.77 |
| Current Ratio | 4.41 |
| Book Value Per Share | 2.08 |
| 52-Week Change | 73.2 |
| 52-Week High | 122.2 |
| 52-Week Low | 45.91 |
| Moving Average 50 Days | 95.55 |
| Moving Average 200 Days | 96.87 |
| Average Volume | 841,757 |
| Shares Outstanding | 68.29M |
| % Held by Institutions | 113.28 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |